Summary
The association between renal failure and obstructive jaundice is a well-known clinical setting. Despite numerous clinical and experimental contributions on this topic we are still far from defining the etiology and pathogenesis of renal failure complicating obstructive jaundice. The aim of this chapter is to assess the current extent of the problem, with a close analysis of pathophysiological data concerning the “hepato-renal syndrome”.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pain JA, Cahill GJ, Bailey ME. Perioperative complications in obstructive jaundice: therapeutic considerations. Br J Surg 1985; 72: 942–959.
Wait RB, Kahng KU. Renal failure complicating obstructive jaundice. Am J Surg 1989; 157: 256–263.
Fogarty BJ, Parks RW, Rowlands BJ, Diamond T. Renal dysfunction in obstructive jaundice. Br J Surg 1995; 82: 877–884.
Clairmont P, Von Haberer H. Ueber anurie nach gallensteinoperationen. Grenzgeb Med Chir 1911; 159–172.
Helwig FC, Schutz CB. A liver kidney syndrome. Clinical pathological and experimental studies. Surg Gynecol Obstet 1930; 55: 570–580.
Heyd CG. “Liver deaths” in surgery of the gallbladder. JAMA 1931; 97: 1847–1848.
Cahill CJ. Prevention of postoperative renal failure in patients with obstructive jaundice-the role of bile acids. Br J Surg 1983; 70: 590–595
Farinon AM, Rulli F, Percudani M, Muzi M, Baratta V. Urinary sodium levels related to jaundice duration in the assessment of postoperative risk of hepato-renal syndrome in eldely patients undergoing surgery for biliary obstruction. It J Surg Sci 1989; 19: 11–17.
Willimas RD, Elliot DW, Zollinger RM. The effect of hypotension in obstructive jaundice. Arch Surg 1960; 81: 334–340.
Dawson JL. The incidence of postoperative renal failure in obstructive jaundice. Br J Surg 1965; 52: 663–665.
Wittenstein BH, Giacchino JL, Pickleman JR et al. Obstructive jaundice: the necessity for improved management. Am Surg 1981; 47: 116–120.
Armstrong CP, Dixon JM, Taylor TV, Davies GC. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg 1984; 71: 234–238.
Aoyagi P, Lowenstein N. The effects of bile acids and renal ichemia on renal function. J Lab Clin Med 1968; 71: 686–692.
Emerson WC. The toxic constituents of bile. J Lab Clin Med 1929; 14: 635–641.
Parkinson TM, Olson JA. Inhibitory effects of bile acids on adenosin triphophatase oxigen consumption and the transport and diffusion of water-soluble substances in the small intestine of the rat. Life Sci 1964; 3: 107–119.
Weissman G. Studies of lysosomes. The effects of neutral steroids and bile acids on lysosomes in vitro. Biochem Farmacol 1965; 14: 525–536.
Weissman G, Kaiser H. Hemolysis and augmentation of hemolysis by neutral steroids and bile acids. Biochem Farmacol 1965; 14: 537–546.
Wardle EN. Renal failure in obstructive jaundice. Pathogenetic factors. Postgrad Med J 1975; 51: 512–514.
Farinon AM, Rulli F, Muzi M, Torquati A, Villani A, Bosco M, Bonomo V, De Sole P, Antenucci M. Effects of common bile duct ligation on the renal function in rats. Progress Report 1991; 3: 45–55.
O’Connor M. Mechanical biliary obstruction. A review of the multisystemic consequence of obstructive jaundice and their impact on perioperative morbidity and mortality. Am Surg 1985; 51: 245–251.
Wilkinson SP, Moodie H, Stamatakid JD. Endotoxinemia and renal failure in cirrhosis and obstructive jaundice. Br Med J 1976; 2: 1415–1418.
Arieff AL, Chidsey CA. Renal function in cirrhosis and the effects of prostaglandine A. Am J Med 1974; 56: 695–703.
Fichman MP, Littenburg G, Horton R. Effect of prostaglandin A on renal and adrenal function in man. Cire Res 1972; 30: 19–35.
Staudacher V, Nespoli A, Chiara O, Bigatello L, Loda M, Di Pace C. Ipertensione portale: cenni di terapia ragionata. Federazione Medica 1982; 9: 939–952.
Zusman RM, Axelrod L, Tolkoff-Rubin N. The treatment of the hepato-renal syndrome with intra-renal administration of prostaglandins. Prostaglandins 1977; 13: 819–830.
Kennedy AC, Burton JA, Luke RG, Bridges JD, Lindsay RM, Ellison MEM, Edwards N, Dargie HS. Factors affecting the prognosis in acute renal failure: a survey of 251 cases. Quart J Med 1973; 42: 73–86.
Koppel MH, Coburn JV, Matlock M, Mims MM, Goldstein H, Boyle J, Rubini ME. Transplantation of cadaveric kidneys from patients with hepato-renal syndrome. Evidence for the functional nature of renal failure in advanced liver diseases. N Engl J Med 1969; 280: 1367–1370.
Marshall VC. Acute renal failure in surgical patients. Br J Surg 1971; 58: 17–21.
Morrison DC, Ulevic TCHJ. The effect of bacterial endotoxins on host mediation system. A review. Am J Pathol 1978; 93: 527–617.
Muller-Berghaus G. The role of platelets, leucocytes and complement in the activation of intravascular coagulation by endotoxin. In: de Gaetano G, Garattini S, eds. Platelets: a multidisciplinary approach. New York: Raven Press, 1978: 303–320.
Wardle EN, Wright NA. Endotoxin and renal failure associated with obstructive jaundice. Br Med J 1970; 4: 472–474.
Wardle EN. Endotoxaemia and the pathogenesis of acute renal failure. Quart J Med 1975; 44: 389–398.
Sagar S, Shields R. Fibrinogen in the hepato-renal syndrome: an experimental study. Br J Surg 1980; 67: 562–564.
Fletcher MS, Westwick J, Kakkar VV. Endotoxins, prostaglandins and renal fibrin deposition in obstructive jaundice. Br J Surg 1982; 69: 625–629.
Wardle EN. Fibrinogen disease. Arch Surg 1974; 109: 741–746.
Wilkinson SP, Arroyo V, Gazard BG, Moodie H, Williams R. Relation of renal impairment and haemorragic diathesis to endotoxaemia on fulminant hepatic failure. Lancet 1974; i: 521–524.
Fisher JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971; ii: 74–79.
Nespoli A, Bevilacqua G, Staudacher G, Rossi N, Salerno F, Castelli MR. The role of false neurotransmitters in the pathogenesis of hepatorenal encephlopathy and hyperdinamic syndrome in cirrhosis. Arch Surg 1981; 116: 1129–1138.
Cattell WR, Birnsting MA. Blood-volume and hypotension in obstructive jaundice. Br J Surg 1967; 54: 272–278.
Bomzon L, Wilten PB, McCalden TA. Impaired skeletal muscle vasomotor response to infused noradrenaline in baboons with obstructive jaundice. Clin Sci 1978; 55: 109–112.
Finberg JPM, Syrop HA, Better OS. Blunted pressor response to angiotensin and sympathomimetic amines in bile duct ligated dogs. Clin Sci 1981; 61: 535–539.
Nakayama T, Ikeda A, Okuda K. Percutaneous transhepatic drainage of the biliary tract technique and results in 104 cases. Gastroenterology 1978; 74: 554–559.
Hatfield ARW, Terblanche J, Fataar S. Preoperative external biliary drainage in obsructive jaundice. Lancet 1982; ii: 896–899.
Pitt HA, Gomes AS, Lois JF, et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 1985; 201: 545–553.
Speer AG, Russell RCG, Hatfield ARW et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987; ii: 57–62.
Lygidakis NJ, van der Heyde MN, Lubbers MJ. Evaluation of preoperative biliary drainage in the surgical management of pancreatic head carcinoma. Acta Chirurgica Scandinavica 1987; 153: 665–668.
Trede M, Schwall G. The complications of pancreatectomy. Ann Surg 1988; 207: 39–47.
Better OS, Chaimovitz C. The hepato-renal syndrome. In: Disease of the kidney. Edited by R.W. Scrier, CW, Gohschalk. Boston-Toronto, Little Brown, 1988, 1489–1500.
Amodio P, Rigotti P, Bazzerla G, et al: Are urinary enzymes useful markers of kidney damage in obstructive jaundice? Nephron 1985; 39: 377–381.
Burchard U, Haschen RJ, Krosch H: Clinical usefulness of enzyme determinations in urine; in Dubach, Schidt (ed): Diagnostic significance of enzyme and proteins in urine. Bern, Huber, 1979, pp 106.
Bonini PA, Guamieri GF, De Nadai-Frank A, et al: Significato fisiopatologico e applicazioni cliniche degli enzimi urinari. Quad Sclavo Diagn 1973; 9: 419–441.
Ceriotti G, Bonini PA: Specificita dell’alfa-glucosidasi urinaria nelle lesioni citolitiche del tubulo renale. Minerva Nefrol 1971; 18: 126.
Peters J.E., Mampel E, Schneider SI. Alaninaminopepptidase (L-Alanyl-Peptidhydrolase) im Urin bei Nierenrkrankungen. Clin chim Acta 1972; 37: 213.
Mirouze D, Michel H. Le syndrome hepatorenal. Presse Med 1983; 12: 36–40.
Papper S. Hepatorenal syndrome. Contrib Nephrol 1980; 23: 55–74.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Farinon, A.M., Rulli, F., Zanella, E. (1999). Renal failure complicating obstructive jaundice. An updating. In: Zanella, E. (eds) Advances in Abdominal Surgery. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4469-8_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-4469-8_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5914-5
Online ISBN: 978-94-011-4469-8
eBook Packages: Springer Book Archive